chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report received from a patient on 06 December 2006.  A 32 year old, female patient (with a medical history of seasonal allergies and allergies to antibiotics, but no egg allergy) developed hives around eyes and legs, slight tightness with breathing and her skin on her face felt like burning, on the evening after receiving an injection of Fluzone (lot number unknown, site of administration not reported) in the right deltoid on 18 November 2006.  She did not have any illness at the time of vaccination.  4-5 days post dose, she had right axillary lymphadenopathy.  Her signs and symptoms resolved in 5 days and the patient recovered.
Rash around groin, sensitive hands and feet, waking up around 4am sweating.
pt stated she feel "off". She feels like she is going to fall asleep. Difficulty seeing, states feels like she does not have her glasses on,  Pt has pacemaker.  HR 60, BP 102/70, O2 97%. EMS called
Urticaria, Temperature 99-100 day after receiving immunizations, continued on day 2 treated with per mouth benadryl.
Patient was administered Pfizer COVID-19 vaccine and fainted during her 15 minute observation time. Mother alerted pharmacy staff. Pharmacist observed patient regain consciousness. Patient reported feeling warm, was sweating, and saw spots of light. Patient was given a bottle of water and and instant cold ice pack. Patient observation time was continued. After fifteen minutes patient was feeling better and left pharmacy with mother.
Nails and hair have stopped growing and blood is not coagulating when I had a tiny cut on my finger.  It took 2 days wearing a bandage before the cut stopped bleeding.
Hives, itching, sharp bumps, stinging. Treatment = BENADRYL, hydrocortisone cream. Notified our office on 12/17/13.
Reported subcutaneous crepitus, soreness at injection site that lasted for 24 hours.
6/7/17 Vaccines administered. 6/12/17 Headache-worsens w/eye movement. 6/14/17 Slight improvement w/headache. Developed shoulder pain, both sides, worse on (R) side intermittently. 6/15/17 Follow-up in our office.
Patient stated that the shot hurt and was painful afterwards. I informed patient to sit in waiting area. Went to check on patient after processing another shot and prescriptions, patient stated that it was really painful. Advised patient to take Tylenol for pain, fever, or flu-like symptoms. Patient asked advice for weakness also, I advised patient to rest there after which I went back into the pharmacy to process scripts. Patient's spouse received M-M-R II shot this evening also but had no reaction. When I got back to check on patient, they had already left . I called the patient around 8:15 pm  and the next day 10/09/2020 around 9:40am but neither calls were answered
Intense itching in an area about two inches below injection site which started about six days after the first injection of Moderna vaccine.  Also swelling ( a firm lump).  Itching intense enough to disrupt sleep.    Over the counter remedies did not help. Cold pack did not help.
Information has been received from a registered nurse referring to a patient of unknown age and gender. On 17-SEP-2015 (also reported as today) the patient was vaccinated with an improperly stored dose of GARDASIL 9 (dose, strength were unknown, lot # L011846, expiry date: 16-JUN-2017, intramuscular). No adverse effects were reported. This is one of several cases received from the same source. Additional information has been requested.
The day of vaccination I felt like I was on steroids.  I had lots of energy and felt a bit aggressive.  The next four days I was exhausted and needed to sleep a lot.
8:50 PM 9/19 vaccine administered. Pt left pharmacy at 9:02 PM. Pt complained to mom about cold/numb fingertips swollen face, swollen lips, dizziness, swollen eyes at 9:30 PM. Pt went to emergency room via ambulance at 9:45 PM. She had difficulty breathing, blood pressure dropped. ER administered BENADRYL, prednisone.
Chest pain; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) and COUGH (Coughing) in a 54-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ulcerative colitis.    Concomitant products included TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.   In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 24-Jun-2022, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced CHEST PAIN (Chest pain) and COUGH (Coughing). At the time of the report, CHEST PAIN (Chest pain) and COUGH (Coughing) outcome was unknown.            MPID number of Moderna Covid-19 vaccine was reported. The reporter's causality for the events of coughing and chest pain with Adalimumab Solution for Injection was Not Provided. No treatment medications were provided.
She had two initial shots of Pfizer vaccine and no issues. Had first booster in Jan2022. All have been Pfizer; She had two initial shots of Pfizer vaccine and no issues. Had first booster in Jan2022. All have been Pfizer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and in Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "She had two initial shots of Pfizer vaccine and no issues. Had first booster in Jan2022. All have been Pfizer". Clinical course: She had two initial shots of Pfizer vaccine and no issues. Had first booster in Jan2022. All had been Pfizer. Not had any boosters after that. Not had Covid at all until a couple of months ago and she got Covid. She never had any problem with that or trouble breathing.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300370259 same patient, different dose/AE.;
Red lump the size of a nickel. Area warm to touch. Had 1/2 inch streaks around the site that extended to under his arm towards the arm pit.
Stomach pain/lack of appetite/weightloss.  Ear ringing in right ear.  Missed period for Nov  2021and Dec 2021, March 2022, June 2022, July 2022.
Visibly swollen lymph nodes on right side of neck. I felt two.  Took him to Dr. and the Dr. felt multiple.  Said it was unrelated to MMR shot.  Very unlikely that is the case.  My son had not been sick at all.  This was the only change.  Lymph nodes may have been swollen earlier but were noticed on 4/20/14.
First adverse event was on Day 8, after the initial rash and soreness at the injection site had disappeared, I got another circle shaped red, raised inflammation that was hot to the touch, and itched and burned. The second more serious issue that when I turned my head on my pillow upon waking at 4 AM on Day 13 after the vaccine, the entire room started spinning. I had vertigo so bad for 2 days I could hardly walk - and didn't when necessary. Since then it's gotten better or worse on different days. I still am having serious issues sometimes with dizziness and balance.
lost about 22-25 pounds; chronic diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, . The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "IBSD" (unspecified if ongoing), notes: States she does have a history of IBSD but this is beyond the that. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose 3 (Booster)), for COVID-19 Immunization; Bnt162b2 (Dose:2), for COVID-19 Immunization; Bnt162b2 (Dose:1), for COVID-19 Immunization. The following information was reported: DIARRHOEA (non-serious) with onset 2022, outcome "not recovered", described as "chronic diarrhea"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "lost about 22-25 pounds". The event "chronic diarrhea" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The reporter states she has had this for a long time and has not find real answers, so she thinks the COVID Vaccine could be a real possibility of the cause but she doesn't know for sure.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Severe and prolonged (18-24) crying, irritability and fever (102), mild local reaction, but tender. Pt. also with very mild uri and mild/minimal right otitis media.
the day got vax had no fever, no irritability;next day about noon began inc fever 103 R all day;given APAP;next day 21DEC97 pt taken to ER w/T103;MD prescribed ATB & pediaprofen & temp dec w/in 15min;
Patient received Covid vaccine at 10:17am. Left exam room to wait for 15 minutes. At 10:20 am patient felt light headed and began to fall. Medical Assistant and help lowered patient to the floor. Head was protected . Patient began to have tonic clonic posturing for about 30 seconds that stopped. Emesis x2 yellow in coloring. Blood pressure 121/78, Blood glucose 90, and pulse oximetry was 95%. Doctor assessed and paramedics were called. Paramedics arrived  at 1030 am and transported patient to the ER.
Per mother via translator, child making crazy statements; not himself; acting drunk for approx 3hrs.  Symptoms resolved without any further problems; however child does not have a memory of the 3 hours with symptoms
No adverse effects were reported; the patient was administered an improperly stored dose of Vaqta; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 22-OCT-2019, the patient was vaccinated with improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) injection, lot # S007770 and expiration date 24-JUL-2020 (exact dose and route of administration were not reported) for prophylaxis. No adverse effects were reported. The temperature was below 37°F (32.7F) for 3 hours and 20 minutes, and above 47°F (52F) for 39 minutes. Previous temperature excursion was above 47°F (50.2F) for 31 minutes. Digital data logger was involved.
1- Extremely sore breasts following the vaccination which hasn't subsided, and in fact have become painful as they're very sore and even swollen. 2 - I have also become increasingly fatigued and it seems to be getting worse. None of this was an issue prior to the second vaccine dose and these two worrying symptoms appear to be  worsening each day rather than subsiding.   I have yet to seek out a doctor as I'm worried about cost and dismissiveness. I will by week's end if nothing changes.
As in the previous two Pfizer Covid-19 vaccinations I received in 2020, the third, administered by Drugs store, within hours became very tired and over the course of four days, was too tired to do anything but sleep for about 18 hours a day.  Site where shot administered has about a two-inch discolored (red) patch a week later.
Itchiness, achy pain, redness 2-2 1/2 inches around it is ound arm from incection site.
Patient sat on exam table to receive vaccine in right thigh.  Child relaxed and compliant.  After vaccine stood up unaided form exam table and passed out - fell forward and hit his head on the floor.  Immediately laid down on the floor by staff and he regained consciousness.  Ice pack applied to forehead and mouth - teeth cut into lip with impact of fall.  Evaluated by MD, vital signs taken and given pedialyte popsicle to suck on.  As he improved, sat up and then taken to car in a wheel chair.  Vomited x1 4 hours later at home.  Complained of headache and some nausea since the fall and was re evaluated in the office on Monday 10/21 for concussion.  Currently following the concussion protocol with limited activity and school attendance.  to be re evaluated in office 10/29 or sooner if worsening symptoms.
quick onset exhaustion Narrative:  Pt reports receiving latest COVID booster shot Friday, 6/3/2022. She reports feeling exhausted about 2 hours after the shot. The next day, she reports being fine. Pt states it seems like the onset of exhaustion is coming faster, but last shorter the more injections received.
Swollen joints, hand and wrist and elbow pain, chronic fatigue, muscle aches, arthritis, depression, weak clasp in hands, headaches, flu symptoms.
It was reported that a 29-year-old female patient received a TD Adult vaccination on 4/3/01 at 4:00pm. Reportedly on 3/24/01 at 12:00pm, the patient's arm became sore and red, developed a headache. On 3/25/01 the injection site reaction was getting larger, redness increased and became warm to the touch, hard knot developed. The patient still has a hard knot and little redness. From additional correspondence received on 5/15/01, it was reportedt that no other vaccines were given on 3/22/01. The patient has recovered from this adverse experience. This case is closed.
Initially after receiving the vaccine I was sleepy and tired. I also had a swollen arm and soreness at the injection site. Then in March 2022 I caught Covid. I had no fever, but I had body aches, extreme fatigue, and a scratchy throat. I had tested negative for Covid, but when I called my doctor they said I did have Covid despite the negative result. I was prescribed Paxlovid for five days. It relieved my symptoms, and I feel 100% better except I still have the fatigue. I also don't have my normal energy back either.
syncope; fell and fractured his jaw; This spontaneous report was received from a physician, via a company representative, and refers to a 12-year-old male. No information was provided regarding the patient's medical history, concurrent conditions, previous drug reactions, allergies and concomitant medications.  On 27-DEC-2021, the patient was vaccinated with the first dose of with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot #1775809, expiration date: 18-AUG-2023 (strength, dose, route of administration and anatomical location were not reported) for prophylaxis. The patient also received meningococcal vaccine a/c/y/w conj (dip tox) (MENACTRA) and an unspecified flu vaccine at the same visit (strengths, doses, routes of administration, anatomical locations, lot numbers and expiration dates were not reported).  On that same day, the patient did not wait 15 minutes after immunization as recommended and was standing at the checkout desk with his parent and experienced syncope. The patient fell and fractured his jaw (Jaw fracture). The patient did have to go to urgent care and received stitches. The patient also had to go to a orthodontic. The patient recovered form the events on an unknown date ("had since recovered") and curreny was okay. The action taken with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not applicable.   The causal relationship between the events and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not reported.  Upon internal review, the events jaw fracture and syncope were determined to be medically significant.
17-year-old received the first shot of moderna vaccine; A spontaneous report was received from a nurse concerning a 17-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced 17-year-old received the first shot of Moderna vaccine.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, approximately 0 days prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient received their first dose of the vaccine at 17 years old. She was turned away from getting her second dose due to her age. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was unknown.   The event, 17-year-old received the first shot of Moderna vaccine, was considered resolved on an unknown date.; Reporter's Comments: This case report concerns a non-serious unexpected event of 17-year-old received the first shot of Moderna vaccine (inappropriate age at vaccine administration  for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of inappropriate age at vaccine administration.
Vaccination site erythema, induration, tenderness lasting more than 1 month; worsening after each anthrax vaccination. Right sided axillary adenopathy; no constitutional symptoms. Muscle Pain Start: 9/17/2004 - Fatigue Start: 9/17/2004 - Lymphadenopathy, axillary Start: 10/15/2004 - Right side only
ON 2/16/09 PATIENT HAD A SEVERE HEADACHE, WAS SEEN IN DOYLESTOWN HOSPITAL, PARIENT HAD HAD A HEADACHE EVER SINCE. IS SEEING FAMILY PHYSICIAN, A NEUROLOGIST AND HAS SEEN 2 ENT PHYSICIANS. HAS HAD ANTIBIOTICS, CT SCAN, MRI AND LAB TESTING.
Patient says he experienced tingling in face and lower arms 2.5 hours after vaccination. Patient says the next morning, when he awoke, the symptoms were gone.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 11:22 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 11:22 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 78.96.  No concomitant medications were reported.  On 11-Jan-2021, excursion time was 9 AM, temperature was 34 and 2 PM, temperature was 35. Total doses given for the day was 98, condition of vaccine prior to administration was not frozen. The vial was initially moved to the fridge on 08-Jan-2021 and beyond use date was 07-Feb-2021. 9 vials were sent to clinic on 11-Jan-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Right forearm began tingling; Itchy; Painful arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Right forearm began tingling), PRURITUS (Itchy) and PAIN IN EXTREMITY (Painful arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PARAESTHESIA (Right forearm began tingling), PRURITUS (Itchy) and PAIN IN EXTREMITY (Painful arm). On 01-Feb-2021, PARAESTHESIA (Right forearm began tingling) and PRURITUS (Itchy) had resolved. At the time of the report, PAIN IN EXTREMITY (Painful arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment.
3 days after vaccination, I started having 2-3 bloody  noses per day.  I rarely have bloody noses other than following this shot.  The multiple bloody noses went on for 2-3 weeks and then started slowly tapering off.   My last bloody nose was May 30, 2021 and I haven't had any more since.
developed  painful lesion 2 days after receiving her third vaccine.  Similarly, she developed multiple vaginal sores after her second dose.  Symptoms began with general soreness of the area that developed into open wounds which were very painful.  was unable to work or attend school for 7 days due to the pain.  Steroids eventually contributed to healing of the area and reduction of the pain.
Patient complained of sensory changes, specifically a change in taste following the vaccine, and an itchy feeling in the back of her throat.  She also described a tingling sensation at the site of the injection and an overall feeling of itchiness.  She stated that she suddenly did not feel well. She was assessed by ALS paramedics. Physician on-site administered 50mg diphenhydramine PO, and Epi-Pen to her right anterolateral thigh, then Epi-Pen to left anterolateral thigh five minutes later because her abnormal sensations continued.  Her BP was ~250/203 and her heart rate did not increase following administration of epinephrine.
Moderna 4/8/21, 5/6/21. Pfizer 1/25/22. Positive on 10/5/22.
LEFT ARM ERYTHEMA, WARM TO TOUCH, PRURITIS, PAIN, SWELLING
Within 15 min. after administering vaccine child started with swelling of lips, tongue; hives over body, difficulty breathing - administered BENADRYL by mouth; 0.3 ml Epinephrine; albuterol sulfate via nebulizer.
Itchy red spot developed 3/15 about the size of a penny. Today 3/17 spot is 1.5" across, red, intensely itchy, and a notable sore swelling underneath the red spot is 2" in diameter, hard, and hot to the touch. Hydrocortisone and triamcinolone in conjunction with diphenhydramine have been given with no noticeable change. At present this is the only notable event.
There was some swelling at site of injection after this HPV vaccine and it went away in days. There is now a bump at injection site that appeared weeks later and its tender.
Varicella vaccine breakthrough.  Diagnosed with Varicella on 03/03/2006.  Rash started on 03/01/2006.  Had 11 spots, some with vesicles spread over body.  No fever.
Sister had chicken pox previously. Pt became symptomatic 12/30/03 with few lesions, probably 10 today. No fever.